Biotechnology GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom – GRI Bio (NASDAQ:GRI) Read more
Biotechnology Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis – Enlivex Therapeutics (NASDAQ:ENLV) Read more
Biotechnology Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease – Eli Lilly (NYSE:LLY), Better Therapeutics (NASDAQ:BTTX) Read more